US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial chylomicronemia syndrome as an adjunct to diet: Carlsbad, California Monday, December 23, 2024, 15: ...
A new prediction model for infected pancreatic necrosis (IPN) in patients with acute pancreatitis (AP) offers a groundbreaking approach to improving patient outcomes.